Titan Pharmaceuticals Inc. is developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company's lead product is Probuphine®, the first and only commercialized treatment of opioid dependence to provide continuous, around-the-clock blood levels of buprenorphine for six months following a single procedure. It was approved by the U.S. Food and Drug Administration in May 2016 and is being commercialized in the U.S. by partner Braeburn Pharmaceuticals. Probuphine employs Titan's proprietary drug delivery system ProNeura™, which is capable of delivering sustained, consistent levels of medication for up to 12 months. The ProNeura technology has the potential to be used in developing products for treating other chronic conditions such as Parkinson's disease and hypothyroidism, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
View Top Employees from Titan PharmaceuticalsWebsite | http://www.titanpharm.com |
Ticker | TTNP |
Revenue | $3 million |
Funding | $18.4 million |
Employees | 33 (31 on RocketReach) |
Founded | 1992 |
Address | 400 Oyster Point Boulevard Ste. 505, South San Francisco, California 94080, US |
Phone | (650) 244-4990 |
Fax | (650) 244-0715 |
Technologies |
JavaScript,
HTML,
Twitter
+29 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Healthcare, Science and Engineering, Drug Delivery, Medical, Health Care, Therapeutics |
Web Rank | 4 Million |
Keywords | Titan Pharmaceuticals, Ttnp, Probuphine, Press Release Reverse Sock Split, Pharm "Financing Agreement" "Annual Report" |
Competitors | AGY Therapeutics, Inc., ALSERES PHARMACEUTICALS INC, BIONOMICS LIMITED, Boston Life Sciences Inc, TARIS Bio |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Titan Pharmaceuticals employee's phone or email?
The Titan Pharmaceuticals annual revenue was $3 million in 2024.
Kate DeVarney is the President and Chief Operating Officer of Titan Pharmaceuticals.
31 people are employed at Titan Pharmaceuticals.
Titan Pharmaceuticals is based in South San Francisco, California.
The NAICS codes for Titan Pharmaceuticals are [32, 325, 32541, 3254].
The SIC codes for Titan Pharmaceuticals are [28, 283].